These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10367337)

  • 41. A novel arsenic methyltransferase gene of Westerdykella aurantiaca isolated from arsenic contaminated soil: phylogenetic, physiological, and biochemical studies and its role in arsenic bioremediation.
    Verma S; Verma PK; Meher AK; Dwivedi S; Bansiwal AK; Pande V; Srivastava PK; Verma PC; Tripathi RD; Chakrabarty D
    Metallomics; 2016 Mar; 8(3):344-53. PubMed ID: 26776948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arsenic carcinogenesis in the skin.
    Yu HS; Liao WT; Chai CY
    J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
    Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
    Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
    Liu J; Xie Y; Ward JM; Diwan BA; Waalkes MP
    Toxicol Sci; 2004 Feb; 77(2):249-57. PubMed ID: 14691202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arsenicosis: review of recent advances.
    Pimparkar BD; Bhave A
    J Assoc Physicians India; 2010 Oct; 58():617-24, 629. PubMed ID: 21510113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AS3MT-mediated tolerance to arsenic evolved by multiple independent horizontal gene transfers from bacteria to eukaryotes.
    Palmgren M; Engström K; Hallström BM; Wahlberg K; Søndergaard DA; Säll T; Vahter M; Broberg K
    PLoS One; 2017; 12(4):e0175422. PubMed ID: 28426741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the carcinogenicity of inorganic arsenic.
    Cohen SM; Arnold LL; Beck BD; Lewis AS; Eldan M
    Crit Rev Toxicol; 2013 Oct; 43(9):711-52. PubMed ID: 24040994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arsenic Disruption of DNA Damage Responses-Potential Role in Carcinogenesis and Chemotherapy.
    Muenyi CS; Ljungman M; States JC
    Biomolecules; 2015 Sep; 5(4):2184-93. PubMed ID: 26404387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Environmental arsenic exposure: From genetic susceptibility to pathogenesis.
    Minatel BC; Sage AP; Anderson C; Hubaux R; Marshall EA; Lam WL; Martinez VD
    Environ Int; 2018 Mar; 112():183-197. PubMed ID: 29275244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health effects of early life exposure to arsenic.
    Vahter M
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):204-11. PubMed ID: 18226075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
    Rager JE; Tilley SK; Tulenko SE; Smeester L; Ray PD; Yosim A; Currier JM; Ishida MC; González-Horta Mdel C; Sánchez-Ramírez B; Ballinas-Casarrubias L; Gutiérrez-Torres DS; Drobná Z; Del Razo LM; García-Vargas GG; Kim WY; Zhou YH; Wright FA; Stýblo M; Fry RC
    Chem Res Toxicol; 2015 Jun; 28(6):1144-55. PubMed ID: 26039340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transgenic Drosophila model for arsenic methylation suggests a metabolic rationale for differential dose-dependent toxicity endpoints.
    Muñiz Ortiz JG; Shang J; Catron B; Landero J; Caruso JA; Cartwright IL
    Toxicol Sci; 2011 Jun; 121(2):303-11. PubMed ID: 21447609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular arsenic transport pathways in mammals.
    Roggenbeck BA; Banerjee M; Leslie EM
    J Environ Sci (China); 2016 Nov; 49():38-58. PubMed ID: 28007179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
    Hayakawa T; Kobayashi Y; Cui X; Hirano S
    Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenomic reprogramming in inorganic arsenic-mediated gene expression patterns during carcinogenesis.
    Eckstein M; Eleazer R; Rea M; Fondufe-Mittendorf Y
    Rev Environ Health; 2017 Mar; 32(1-2):93-103. PubMed ID: 27701139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arsenic-induced changes in the gene expression of lung epithelial L2 cells: implications in carcinogenesis.
    Posey T; Weng T; Chen Z; Chintagari NR; Wang P; Jin N; Stricker H; Liu L
    BMC Genomics; 2008 Mar; 9():115. PubMed ID: 18315880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.
    Drobná Z; Waters SB; Devesa V; Harmon AW; Thomas DJ; Stýblo M
    Toxicol Appl Pharmacol; 2005 Sep; 207(2):147-59. PubMed ID: 16102566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM; Simile MM; Feo F
    Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding arsenic carcinogenicity by the use of animal models.
    Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of arsenic toxicity, speciation and polyadenylation of canonical histones.
    Costa M
    Toxicol Appl Pharmacol; 2019 Jul; 375():1-4. PubMed ID: 31077704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.